新型生物标志物与生物标志物在炎症性肠病中的未来潜力
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.
作者信息
Duvoisin Gilles, Lopez Robert N, Day Andrew S, Lemberg Daniel A, Gearry Richard B, Leach Steven T
机构信息
Department of Paediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Department of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, Australia.
出版信息
Mediators Inflamm. 2017;2017:1936315. doi: 10.1155/2017/1936315. Epub 2017 Apr 16.
Abstract
There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility. This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.
摘要
肠道炎症的非侵入性评估正变得越来越重要。这些工具可能是区分肠道炎症性疾病与功能性疾病以及监测已知炎症状态个体对干预反应的关键。尽管目前有多种非侵入性标志物可用，但它们存在局限性，无法提供理想的效用。本综述重点关注肠道炎症的新兴标志物，突出特定标志物的潜力。
相似文献
1
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.新型生物标志物与生物标志物在炎症性肠病中的未来潜力
Mediators Inflamm. 2017;2017:1936315. doi: 10.1155/2017/1936315. Epub 2017 Apr 16.
2
Biomarkers of Inflammation in Inflammatory Bowel Disease.炎症性肠病的炎症生物标志物。
Gastroenterology. 2015 Oct;149(5):1275-1285.e2. doi: 10.1053/j.gastro.2015.07.003. Epub 2015 Jul 9.
3
Chromogranin A and other enteroendocrine markers in inflammatory bowel disease.嗜铬粒蛋白A及其他肠道内分泌标志物与炎症性肠病
Neuropeptides. 2016 Aug;58:127-34. doi: 10.1016/j.npep.2016.01.002. Epub 2016 Jan 12.
4
Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review.拓展挥发性代谢物作为炎症性肠病新型诊断生物标志物的研究领域——综述
Scand J Gastroenterol. 2016;51(4):385-92. doi: 10.3109/00365521.2015.1105286. Epub 2015 Nov 6.
5
Novel new noninvasive biomarkers of inflammatory bowel disease.炎症性肠病的新型无创生物标志物。
Inflamm Bowel Dis. 2008 Sep;14(9):1317. doi: 10.1002/ibd.20440.
6
Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.测定粪便炎症标志物浓度作为评估炎症性肠病患儿病理活动的一种非侵入性方法。
Adv Med Sci. 2015 Sep;60(2):246-52. doi: 10.1016/j.advms.2015.04.003. Epub 2015 Apr 29.
7
Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.替代标志物在预测炎症性肠病复发中的应用。
J Gastroenterol. 2016 Jun;51(6):531-47. doi: 10.1007/s00535-016-1191-3. Epub 2016 Mar 14.
8
Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.粪便钙卫蛋白在炎症性肠病诊断及临床评估中的应用
Scand J Gastroenterol. 2015 Jan;50(1):74-80. doi: 10.3109/00365521.2014.987809.
9
Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?批判性评论：分析新型疗法对炎症性肠病细胞因子表达的影响：细胞因子水平能否反映临床反应？
Int J Colorectal Dis. 2006 Sep;21(6):505-7. doi: 10.1007/s00384-005-0082-5. Epub 2006 Jan 17.
10
Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.炎症性肠病中的蛋白质组学：使用动物模型的方法
Dig Dis Sci. 2017 Sep;62(9):2266-2276. doi: 10.1007/s10620-017-4673-0. Epub 2017 Jul 17.
引用本文的文献
1
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options.炎症性肠病：分子基础、预测生物标志物、诊断方法和治疗选择的综合分析。
Int J Mol Sci. 2024 Jun 27;25(13):7062. doi: 10.3390/ijms25137062.
2
Location is important: differentiation between ileal and colonic Crohn's disease.定位很重要：区分回肠型和结肠型克罗恩病。
Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):544-558. doi: 10.1038/s41575-021-00424-6. Epub 2021 Mar 12.
3
Analysis of Human Faecal Host Proteins: Responsiveness to 10-Week Dietary Intervention Modifying Dietary Protein Intake in Elderly Males.人类粪便宿主蛋白分析：对改变老年男性膳食蛋白质摄入量的10周饮食干预的反应
Front Nutr. 2021 Jan 13;7:595905. doi: 10.3389/fnut.2020.595905. eCollection 2020.
4
Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice.粪便钙卫蛋白检测在儿科胃肠病学临床实践中的应用
Med Princ Pract. 2021;30(4):311-319. doi: 10.1159/000512631. Epub 2020 Oct 29.
5
Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.目前可用的生物标志物在犬炎症性肠病中的临床应用
J Vet Intern Med. 2018 Sep;32(5):1495-1508. doi: 10.1111/jvim.15247. Epub 2018 Sep 17.
6
Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases.非特异性炎症性肠病的诊断标志物。
Dis Markers. 2018 Jun 11;2018:7451946. doi: 10.1155/2018/7451946. eCollection 2018.
本文引用的文献
1
Fecal biomarkers in inflammatory bowel disease.炎症性肠病中的粪便生物标志物。
J Gastroenterol Hepatol. 2017 Mar;32(3):577-582. doi: 10.1111/jgh.13611.
2
Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.测定粪便炎症标志物浓度作为评估炎症性肠病患儿病理活动的一种非侵入性方法。
Adv Med Sci. 2015 Sep;60(2):246-52. doi: 10.1016/j.advms.2015.04.003. Epub 2015 Apr 29.
3
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.炎症性肠病中的微小RNA：矛盾与可能性
Inflamm Bowel Dis. 2015 May;21(5):1160-5. doi: 10.1097/MIB.0000000000000288.
4
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.新型粪便标志物基质金属蛋白酶-9在不同类型炎症性肠病中的诊断价值。
J Crohns Colitis. 2015 Mar;9(3):231-7. doi: 10.1093/ecco-jcc/jjv005. Epub 2015 Jan 12.
5
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.HMGB1作为炎症性肠病患者亚临床肠道炎症和黏膜愈合的合适生物标志物的作用。
Inflamm Bowel Dis. 2014 Aug;20(8):1448-57. doi: 10.1097/MIB.0000000000000113.
6
Pyruvate kinase M2 regulates apoptosis of intestinal epithelial cells in Crohn's disease.丙酮酸激酶 M2 调节克罗恩病中肠上皮细胞的凋亡。
Dig Dis Sci. 2015 Feb;60(2):393-404. doi: 10.1007/s10620-014-3189-0. Epub 2014 May 11.
7
Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.粪便丙酮酸激酶同工酶M2与钙卫蛋白在评估小儿炎症性肠病严重程度及活动度中的比较
Acta Biochim Pol. 2014;61(1):99-102. Epub 2014 Mar 20.
8
Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children.金属蛋白酶-3 和 -9 作为评估儿童溃疡性结肠炎活动的新型标志物。
Adv Clin Exp Med. 2014 Jan-Feb;23(1):103-10. doi: 10.17219/acem/37031.
9
Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.粪便钙卫蛋白、MMP-9 和人β-防御素-2 在小儿炎症性肠病中的水平。
Int J Colorectal Dis. 2014 Jan;29(1):43-50. doi: 10.1007/s00384-013-1775-9.
10
miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease.miR-141 通过靶向 CXCL12β 调节小鼠结肠炎和人类克罗恩病中的结肠白细胞迁移。
Gut. 2014 Aug;63(8):1247-57. doi: 10.1136/gutjnl-2012-304213. Epub 2013 Sep 2.
Zotero 插件